Streamlining Ophthalmology Denial Management for Eye Care Practices

The Nuances of Ophthalmology Denials

Ophthalmology prior authorization often involves high-stakes treatments like anti-VEGF injections for conditions such as wet AMD, diabetic macular edema, and retinal vein occlusion, alongside advanced surgical procedures including premium IOL cataract surgery and complex glaucoma interventions. Denials in these areas are frequently tied to specific clinical documentation requirements and payer policies, demanding a specialized approach to resolution.

Common Denial Triggers in Eye Care

• **Biosimilar Substitution:** Denials for brand-name anti-VEGF drugs (e.g., Eylea, Lucentis) when a biosimilar is mandated by payer policy, requiring specific step-therapy compliance.
• **Documentation Gaps:** Insufficient visual acuity records, OCT findings, or prior treatment response details for continuing anti-VEGF cycles, or inadequate visual field tests for glaucoma surgery and functional blepharoplasty.
• **Cosmetic vs. Medical Necessity:** Discrepancies in documenting medical necessity for oculoplastic procedures like blepharoplasty, leading to denials based on perceived cosmetic intent.
• **Premium IOL Requirements:** Lack of specific documentation or patient acknowledgment for premium intraocular lenses, which often have distinct medical necessity criteria or patient responsibility components.
• **MIGS Policy Variations:** Payer-specific constraints and varying approval policies for micro-invasive glaucoma surgery (MIGS) devices and procedures.

Klivira's Automated Approach to Ophthalmology Denial Management

Klivira's platform is engineered to address the specific complexities of ophthalmology denial management. We automate the intake of denials from X12 835, X12 277, and payer portals, normalizing CARC/RARC codes and payer-specific variations into a uniform reason set. This intelligent processing ensures accurate categorization and routing of denials, whether for claim correction, appeal, or peer-to-peer review, directly impacting efficiency for high-volume chronic anti-VEGF injection cycles.

Intelligent Appeal Packet Assembly for Ocular Procedures

For clinical-necessity denials in ophthalmology, Klivira automates the assembly of comprehensive appeal packets. The system retrieves relevant clinical documentation from the EMR via FHIR, including updated OCT findings, visual field tests, and treatment histories crucial for justifying anti-VEGF continuation or demonstrating medical necessity for oculoplastic procedures. This ensures appeals are submitted with the strongest possible evidence, aligned with AAO Preferred Practice Patterns.

Streamlining the Appeal Workflow

• **Timely Filing Enforcement:** Proactive tracking and alerts for per-payer appeal deadlines prevent lost revenue due to missed windows.
• **Payer-Specific Routing:** Appeals are automatically directed to the correct submission channel (portal API, fax, Da Vinci PAS) and appropriate appeal level, reducing manual errors.
• **Root Cause Analysis:** Klivira identifies denial patterns by payer, provider, and procedure (e.g., anti-VEGF type, premium IOL), providing actionable insights to improve upstream PA submission accuracy.
• **EMR Write-Back:** Appeal outcomes are recorded directly in the EMR, ensuring clinical and billing teams have the latest status for ongoing patient care and financial reconciliation.

Integrating with Your Eye Care Ecosystem

Klivira integrates seamlessly with your existing EMR systems, leveraging SMART on FHIR capabilities to access critical patient data for denial resolution. Our platform connects directly with a vast network of payers, ingesting denial data and submitting appeals through electronic channels where available, minimizing manual touchpoints and enhancing data integrity across your revenue cycle.